Pulmonary and Activation-Regulated Chemokine (PARC; CCL18; MIP-4; DC-CK1). PARC is a chemokine mainly produced by antigen-presenting cells of the innate immune system and is a potential prognostic inflammatory biomarker for Idiopathic Pulmonary Fibrosis (IPF).
Swiss-Prot Accession Number: P55774
A leading global drug discovery and development laboratory, IQVIA Laboratories (the laboratory business of IQVIA) provides customers with a comprehensive assemblage of solutions encompassing central laboratory and specialty biomarker services including genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine assays, vaccine assays, ADME and bioanalytical along with extensive offerings in antibody drug discovery, biomarker discovery, and decentralized clinical trial lab solutions.
Learn more at labs.iqvia.com
Copyright 2026 Rules-Based Medicine. All rights reserved. RBM does not sell your personal information.